EMEA-002418-PIP01-18-M01

Key facts

Active substance
Recombinant Influenza Hemagglutinin-strain A (H1N1 subtype) / Recombinant Influenza Hemagglutinin-strain A (H3N2 subtype) / Recombinant Influenza Hemagglutinin-strain B (Victoria lineage) / Recombinant Influenza Hemagglutinin-strain B (Yamagata lineage) (RIV4)
Therapeutic area
Vaccines
Decision number
P/0219/2019
PIP number
EMEA-002418-PIP01-18-M01
Pharmaceutical form(s)
Solution for injection in pre-filled syringe
Condition(s) / indication(s)
Prevention of influenza infection
Route(s) of administration
Intramuscular use
Contact for public enquiries
Sanofi Pasteur

Tel. +33 437668600
E-mail: piplan@sanofi.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating